About this trial
This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years or older and Danish speaking.
Performance status WHO 0-2
Capable of cooperating on testing
Tumour histology (WHO 2016 classification) of the following types: anaplastic astrocytoma (IDH mutant), diffuse astrocytoma (IDH-mutant), gemistocytic astrocytoma (IDH mutant), diffuse astrocytoma (NOS), oligodendroglioma, meningioma, medulloblastoma (NOS), pituitary adenoma, other brain tumours including skull base sarcomas
Disqualifiers
Glioblastoma
Performance status 3-4 (Karnofsky Performances of 60 or less)
Trial population
The patients will be diagnosed with a primary brain tumour and referred to radiation therapy.
Trial design
Cohort
Prospective
Treatments tested in this trial
Cognitive tests and Patient Reported Outcomes
Other interventionEach patient will undergo cognitive tests and questionnaires
Treatment groups
Trial outcomes
Primary outcomes
Impairment of verbal learning and memory as assessed by the HVLT-r test
Examined by the Hopkins Verbal Learning Test revised. It will be correlated to the mean radiation dose to the hippocampus. Outcome is number of correct words (0-24)
Secondary outcomes
Processing speed I
Examined by the Trail making Test part A (TMT\_A). Outcome for TMT\_A is time in seconds (0-120 seconds).
Processing speed II
Examined by the Coding from Wechsler Adult Intelligence Scale (WAIS-IV). Outcome for Coding is number of correct (within 2 minutes) (0-100)
Attention and working memory
Examined by Wechsler Adult Intelligence Scale (WAIS\_IV\_digit\_span). Outcome on WAIS digit span is number of correct (0-36)
Verbal learning and memory
Examine by the Hopkins Verbal Learning Test revised (HVLT-r) - total and delayed. Outcome is number of correct words (0-24)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.